tbuckley/cabot-search huggingface dataset:
Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Authors: Nicolaus Kroeger, Ernst Holler, Guido Kobbe, Martin Bornhaeuser, Rainer Schwerdtfeger, Arnon Nagler, Wolfgang Bethge, Matthias Stelljes, Lutz Uharek, Hannes Wandt, Marleen van Os, Andreas Burchert, Paolo Corradini, Joerg Schubert, Martin Kaufmann, Peter Dreger, Gerald Wulf, Hermann Einsele, Martin Gramatzki, Tatjana Zabelina, Ulrike Bacher, Axel Zander, Marion Heinzelmann, Michael Kvasnicka, Juergen Thiele, Dietger Niederwieser, Theo de Witte
Journal: Blood (2007)
Identification of New Minor Histocompatibility Antigens (mHags) in Patients with Chronic Graft Versus Host Disease (GvH) after Allogeneic Stem Cell Transplantation by SEREX.
Authors: Joerg Thomas Bittenbring, Manfred Ahlgrimm, Markus Ditschkowski, Frank Neumann, Joerg Schubert, Klaus-Dieter Preuss, Dietrich Wilhelm Beelen, Michael Pfreundschuh
Journal: Blood (2008)
C-JUN-NH2-Terminal Kinase Promotes Apoptosis, Suppresses P-Glycoprotein Mediated Multidrug Resistance but Enhances MRP Mediated Efflux in AML Cells.
Authors: Eleni D. Lagadinou, Panos Ziros, Olga Tsopra, Eleni Thanopoulou, Alexandra Kouraklis, Marina Karakantza, Nicholas C. Zoumbos
Journal: Blood (2006)
Lack of Access to Genetic-Relative Family Health History: A Health Disparity for Adoptees?
Authors: Inmaculada de Melo-Martín
Journal: The American Journal of Bioethics (2016)

In their article May and colleagues (2016) call attention to a feature shared by most adoptees: their lack of access to genetic-relative family health history (GRFHx). They argue that such lack of ...
Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: A Retrospective EBMT Analysis.
Authors: Johannes Schetelig, Anja van Biezen, Dolores Caballero, Martino Rodrigo, Kari Remes, José A. García-Marco, Liisa Volin, José A. Pérez-Simón, Norbert Schmitz, Rainer Schwerdtfeger, Arnold Ganser, Davide Soligo, Brigitte Mohr, Stephan Stilgenbauer, Ronald Brand, Gerhard Ehninger, Theo de Witte, Peter Dreger
Journal: Blood (2007)
Attitudes of Researchers to the Return of Incidental and Targeted Genomic Findings Obtained in a Research Setting to Participants
Authors: Conrad V Fernandez, Denise Avard, Bartha Knoppers, Colleen O'Connell, David Malkin, Caron Strahlendorf, Nada Jabado, Eric Bouffet, Kym Boycott, Poul Sorensen
Journal: Blood (2012)
No Reversal of Demethylation after Azacitidine Treatment in Concordance with Poor Clinical Response.
Authors: Huong Thi Thanh Tran, Hee Nam Kim, JaeSook Ahn, Il-Kwon Lee, Deok-Hwan Yang, Yeo-Kyeoung Kim, Je-Jung Lee, Kyeong-Soo Park, HyeoungJoon Kim
Journal: Blood (2007)
Preleukemia: one name, many meanings
Authors: H P Koeffler, G Leong
Journal: Leukemia (2016)

Definition of preleukemia has evolved. It was first used to describe the myelodysplastic syndrome (MDS) with a propensity to progress to acute myeloid leukemia (AML). Individuals with germline mutations of either RUNX1, CEBPA, or GATA2 can also be called as preleukemic because they have a markedly increased incidence of evolution into AML. Also, alkylating chemotherapy or radiation can cause MDS/preleukemia, which nearly always progress to AML. More recently, investigators noted that AML patients who achieved complete morphological remission after chemotherapy often have clonal hematopoiesis predominantly marked by either DNMT3A, TET2 or IDH1/2 mutations, which were also present at diagnosis of AML. This preleukemic clone represents involvement of an early hematopoietic stem cells, which is resistant to standard therapy. The same clonal hematopoietic mutations have been identified in older 'normal' individuals who have a modest increased risk of developing frank AML. These individuals have occasionally been said, probably inappropriately, to have a preleukemia clone. Our evolving understanding of the term preleukemia has occurred by advancing technology including studies of X chromosome inactivation, cytogenetics and more recently deep nucleotide sequencing.
A Sensor for Low Environmental Oxygen in the Mouse Main Olfactory Epithelium
Authors: Katherin Bleymehl, Anabel Pérez-Gómez, Masayo Omura, Ana Moreno-Pérez, David Macías, Zhaodai Bai, Randall S. Johnson, Trese Leinders-Zufall, Frank Zufall, Peter Mombaerts
Journal: Neuron (2016)

Sensing the level of oxygen in the external and internal environments is essential for survival. Organisms have evolved multiple mechanisms to sense oxygen. No function in oxygen sensing has been attributed to any mammalian olfactory system. Here, we demonstrate that low environmental oxygen directly activates a subpopulation of sensory neurons in the mouse main olfactory epithelium. These neurons express the soluble guanylate cyclase Gucy1b2 and the cation channel Trpc2. Low oxygen induces calcium influx in these neurons, and Gucy1b2 and Trpc2 are required for these responses. In vivo exposure of a mouse to low environmental oxygen causes Gucy1b2-dependent activation of olfactory bulb neurons in the vicinity of the glomeruli formed by axons of Gucy1b2+ sensory neurons. Low environmental oxygen also induces conditioned place aversion, for which Gucy1b2 and Trpc2 are required. We propose that this chemosensory function enables a mouse to rapidly assess the oxygen level in the external environment.
Dose Reduced Conditioning and CD3/CD19 Depletion for Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults: Fast Engraftment and Low Toxicity.
Authors: Wolfgang A. Bethge, Christoph Faul, Martin Bornhaeuser, Peter Lang, Rupert Handgretinger, Lothar Kanz
Journal: Blood (2005)
Phase 1 Dose Escalation Study of the Monoclonal Antibody Against the Insulin Like Growth Factor I Receptor CP-751,871 in Patients with Multiple Myeloma.
Authors: Martha Q. Lacy, Melissa Alsina, Luisa Roberts, Rafael Fonseca, Carrie Melvin, Donghua Yin, Amarnath Sharma, Michael Pollak, Sundar Jagannath, Paul Richardson, Antonio Gualberto
Journal: Blood (2007)
Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.
Authors: Shirong Wang, Auayporn P. Nademanee, Dajun Qian, Andrew Dagis, Hyun-Soon Park, Joy Fridey, Eileen Patricia Smith, David S. Snyder, Ravi Bhatia, Peter M. Falk, Candace Kay, Young Sun Kim, Neil Martin Kogut, Joycelynne Palmer, Joseph Rosenthal, George Somlo, Anthony Selwyn Stein, Shan Yuan, Stephen J. Forman
Journal: Blood (2006)
A Randomized, Placebo-Controlled, Dose-Escalation, Phase 1 Study of the Safety and Pharmacokinetics of Amphotericin B Inhalation Powder in Healthy Subjects.
Authors: Annette Marcantonio, Alan R. Kugler, David Sahner, Nina Mufti, Jonathan D. Lee, Lori K. Samford, Michael A. Eldon
Journal: Blood (2007)
Epstein-Barr Virus-Associated Haemophagocytic Lymphohistiocytosis in Adults Characterised by High Viral Genome Load within Circulating Natural Killer Cells.
Authors: Christopher P Fox, Claire Shannon-Lowe, Philip Gothard, Bhuvan Kishore, Jeffrey R. Neilson, Nigel T J O'Connor, Alan Rickinson, Martin Rowe
Journal: Blood (2009)
Deep Molecular Response Achieved By Second-Generation Tyrosine Kinase Inhibitors (TKIs) Can Lead to Stopping TKIs
Authors: Tetsuro Ochi, Taiichi Kyo, Kayo Toishigawa, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Mitsuhiro Itagaki, Yuta Katayama, Koji Iwato, Hideki Asaoku
Journal: Blood (2015)
Reply
Authors: Arnt V. Kristen, Eva Brokbals, Fabian aus dem Siepen, Ralf Bauer, Selina Hein, Matthias Aurich, Johannes Riffel, Hans-Michael Behrens, Sandra Krüger, Peter Schirmacher, Hugo A. Katus, Christoph Röcken
Journal: Journal of the American College of Cardiology (2016)
A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.
Authors: Sagar Lonial, Stephanie McMillan, Claire Torre, Amelia A. Langston, Ellie Hamilton, Amanda Cook, Christopher Flowers, Jonathan L. Kaufman, Mary Jo Lechowicz, Ned Waller
Journal: Blood (2006)
Novel Evidence That, in Addition to Proteolytic Enzymes, Lipolytic Enzymes Are Involved in Mobilization of Hematopoietic Stem/Progenitor Cells (HSPCs) - an Important Pro-Mobilizing Role Identified for Hematopoietic-Specific Phospholipase C (PLCβ2)
Authors: Sylwia Borkowska, Agata Poniewierska-Baran, Gabriela Schneider, Daniel Pedziwiatr, Malwina Suszynska, Janina Ratajczak, Magdalena Kucia, Mariusz Z Ratajczak
Journal: Blood (2014)
A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement
Authors: Yaolong Chen, Kehu Yang, Ana Marušic, Amir Qaseem, Joerg J. Meerpohl, Signe Flottorp, Elie A. Akl, Holger J. Schünemann, Edwin S.Y. Chan, Yngve Falck-Ytter, Faruque Ahmed, Sarah Barber, Chiehfeng Chen, Mingming Zhang, Bin Xu, Jinhui Tian, Fujian Song, Hongcai Shang, Kun Tang, Qi Wang, Susan L. Norris
Journal: Annals of Internal Medicine (2016)

The quality of reporting practice guidelines is often poor, and there is no widely accepted guidance or standards for such reporting in health care. The international RIGHT (Reporting Items for practice Guidelines in HealThcare) Working Group was established to address this gap. The group followed an existing framework for developing guidelines for health research reporting and the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network approach. It developed a checklist and an explanation and elaboration statement. The RIGHT checklist includes 22 items that are considered essential for good reporting of practice guidelines: basic information (items 1 to 4), background (items 5 to 9), evidence (items 10 to 12), recommendations (items 13 to 15), review and quality assurance (items 16 and 17), funding and declaration and management of interests (items 18 and 19), and other information (items 20 to 22). The RIGHT checklist can assist developers in reporting guidelines, support journal editors and peer reviewers when considering guideline reports, and help health care practitioners understand and implement a guideline.
Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications
Authors: Catherine C. Coombs, Deborah Kuk, Sean Devlin, Robert Siegelbaum, Rekha Parameswaran, Simon Mantha, Gerald A Soff
Journal: Blood (2015)
Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics
Authors: Mazyar Shadman, Sarah Gibson, Claudiu Cotta, Yogen Saunthararajah, Eric Hsi, Edward Copelan, Matt Kalaycio, Mikkael A. Sekeres, Ronald Sobecks, Meagan Effinger, Anjali S. Advani
Journal: Blood (2010)
The Xla (X-linked anemia) Mouse: A Transient Neonatal Anemia Caused by a Gata1 Splicing Mutation,
Authors: Kyle Miller, Michael Silvey, Derek Logsdon, Frederick Balch, Ndona Nsumu, Inna Sokolovsky, Margaret Gibson, Chengpeng Bi, Daniel P. Heruth, Robert A White
Journal: Blood (2011)
Absence of LTB4/BLT1 Axis Promotes Generation of Long-Lasting Antitumor Memory Responses Induced by Administration of GM-CSF Gene-Transduced Tumor Cells, in a CD4+ T Cell-Dependent Manner,
Authors: Yosuke Yokota, Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Koichi Takayama, Yoichi Nakanishi, Takehiko Yokomizo, Kenzaburo Tani
Journal: Blood (2011)
Human and Simian Immunodeficiency Viruses De-Regulate Early Hematopoiesis through a Novel Nef/PPAR-γ/STAT5 Signaling Pathway
Authors: Stéphane Prost, Mikael le Dantec, Sylvie Augé, Roger Le GRAND, Sonia Derdouch, Gwenaelle Auregan, Nicole Déglon, Francis Relouzat, Anne-Marie Aubertin, Bernard Maillere, Isabelle Dusanter-fourt, Marek Kirszenbaum
Journal: Blood (2008)
The Residual Malignant Cells Could Be Masked by Therapeutic Use of Granulocyte-Colony Stimulating Factor in the Patients with AML1/ETO+ Acute Myelogenous Leukemia.
Authors: Hee Won Moon, Ho Young Kim, Young Ree Kim, Han Ik Cho, Sung-Soo Yoon, Seonyang Park, Byoung Kook Kim, Honggu Chun, Hee Chan Kim, Dong Soon Lee
Journal: Blood (2005)
Response to: ‘Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?’ by Nocturne <i>et al</i>
Authors: Louise K Mercer, James B Galloway, Mark Lunt, Rebecca Davies, Audrey AL Low, Will G Dixon, Kath D Watson, Deborah PM Symmons, Kimme L Hyrich
Journal: Annals of the Rheumatic Diseases (2016)

We thank Nocturne et al 1 for their interest and comments on our recent paper, which looked at lymphoma risk over the medium term in a cohort of patients receiving tumour necrosis factor inhibitor (TNFi).1 Overall we found no statistically significant difference in the risk compared with conventional standard disease-modifying antirheumatic drugs (csDMARDs) either for all TNFi exposures combined or when each TNFi was analysed separately in comparison to csDMARDs, using a number of different models to categorise treatment exposure.

We agree that lymphoma is a heterogeneous group of malignancies and that the spectrum of lymphomas seen in people with rheumatoid arthritis (RA) is different from that in the general population, with an over-representation of inflammation-driven diffuse large B-cell lymphoma (DLBCL). Therefore, understanding whether TNFi treatment is associated with an increase in the risk …
Religious Service Attendance and Suicide Rates
Authors: Nancy Krieger
Journal: JAMA Psychiatry (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Psychiatry HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Psychiatry journal
Tuning T Cell Affinity Improves Efficacy and Safety of Anti-CD38 × Anti-CD3 Bispecific Antibodies in Monkeys - a Potential Therapy for Multiple Myeloma
Authors: Gregory L. Moore, Sung-Hyung Lee, Suzanne Schubbert, Yvonne Miranda, Rumana Rashid, Erik Pong, Sheryl Phung, Emily W. Chan, Hsing Chen, Nancy Endo, Maria C. Ardila, Matthew J. Bernett, Seung Chu, Irene W.L. Leung, Umesh Muchhal, Christine Bonzon, David E Szymkowski, John Desjarlais
Journal: Blood (2015)
Reduced Incidence of Acute and Chronic Graft-versus-Host Disease (GvHD) without Increased Relapse in Patients with High-Risk Myeloid Disorders Given Thymoglobulin (THY) as Part of the Transplant Conditioning Regimen: A Dose-Finding Study.
Authors: H. Joachim Deeg, F. R. Appelbaum, B. Storer, M. Cassarella, B. Scott, G. McDonald, R. Storb
Journal: Blood (2004)
Drug Design for Overcoming High-Risk Myeloma and Identification of Novel Binding Proteins to Immune-Modulatory Drugs
Authors: Masashi Hozumi, Daiju Ichikawa, Maiko Matsushita, Eriko Kamiyama, Hiroshi Yanagawa, Noriko Tabata, Shotaro Kitabatake, Arimi Ueda, Takashi Yamaguchi, Mariko Sato, Yutaka Hattori
Journal: Blood (2015)
Innovative Phase I Study of Concomitant and Consecutive Treatment with Dasatinib and MK-0457 in Refractory Ph+ CML and ALL Patients.
Authors: Giovanni Martinelli, Cristina Papayannidis, Ilaria Iacobucci, Simona Soverini, Stefania Paolini, Sandra Santucci, Francesco De Rosa, Daniela Cilloni, Francesca Messa, Fabrizio Pane, Vittorio Meneghini, Panagiota Giannoulia, Emanuela Ottaviani, Nicoletta Testoni, Barbara Lama, Michele Baccarani
Journal: Blood (2009)
Low-Level Bcr-Abl Kinase Domain Mutations Are Very Rare In Chronic Myeloid Leukemia Patients Who Are In Major Molecular Response After 12 Months of First-Line Nilotinib Therapy.
Authors: Simona Soverini, Angela Poerio, Caterina Debenedittis, Ilaria Iacobucci, Sabrina Colarossi, Alessandra Gnani, Fausto Castagnetti, Francesca Palandri, Gabriele Gugliotta, Marilina Amabile, Gianantonio Rosti, Michele Baccarani, Giovanni Martinelli
Journal: Blood (2010)
Abstract 912: Comparison of Coronary Fractional Flow Reserve and Intravascular Ultrasound Measurements for the Evaluation of Intermediate or Equivocal Left Main Coronary Artery Stenosis
Authors: Josep Rodes-Cabau, Javier Courtis, Alvaro Facta, Eric Larose, Jean-Pierre Dery, Jean-Michel Potvin, Melanie Cote, Can M Nguyen, Guy Proux, Robert Delarochelliere, Olivier F Bertrand
Journal: Circulation (2008)
<scp>LEAP</scp>ing through the looking glass: secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introduction
Authors: M. Greenhawt, D. M. Fleischer, E. S. Chan, C. Venter, D. Stukus, R. Gupta, J. M. Spergel
Journal: Allergy (2016)

In the Learning Early About Peanut Allergy (LEAP) study, early peanut introduction in high-risk 4- to 11-month-olds was associated with a significantly decreased risk of developing peanut allergy. However, the influences of key baseline high-risk factors on peanut tolerance are poorly understood.Secondary analysis was conducted on the publically available LEAP dataset, exploring relationships between peanut tolerance, baseline peanut/egg sensitization, eczema severity/duration, age of introduction, gender, and race.A multiple logistic regression model predicting odds of successful oral food challenge (OFC) at 60 months noted higher odds with early introduction (OR 9.2, P < 0.001, 95% CI 4.2-20.3), white race (OR 2.1, P = 0.04, 95% CI 1.1-3.9), and advancing age (OR 4.8, P = 0.04, 95% CI 1.1-20.8). Odds of peanut tolerance were lower with increasing peanut wheal size (OR 0.58, P < 0.001, 95% CI 0.46-0.74), increased baseline SCORAD score (OR 0.98, P = 0.04, 95% CI 0.97-1), and increased kUA /l of egg serum IgE (sIgE) (OR 0.99, P = 0.04, 95% CI 0.98-1). The probability of peanut tolerance in the early introduction group was 83% vs 43% in the avoidance group with SPT wheal of <4 mm. The probability of a successful OFC was significantly higher with peanut introduction between 6 and 11 months than at 4-6 months. Increasing eczema severity had limited impact on the probability of peanut tolerance in the early introduction arm.Increasing peanut wheal size predicted peanut tolerance only in the avoidance arm. Peanut introduction between 6 and 11 months of age was associated with the highest rates of peanut tolerance, questioning the 'urgency' of introduction before 6 months.
Effect of Switching to Nilotinib in Patients with Imatinib-Related Low-Grade Non-Hematologic Adverse Events
Authors: Jeffrey H. Lipton, Michael J. Mauro, Sikander Ailawadhi, Carole B. Miller, Lambert Busque, Luke P. Akard, Javier Pinilla-Ibarz, Solveig G. Ericson, Jinay Shah, Jorge E. Cortes
Journal: Blood (2011)
Activity monitoring in pulmonary rehabilitation in patients with COPD
Authors: Janos Varga, Krisztián Aranyász, Attila Somfay
Journal: European Respiratory Journal (2011)

Introduction: The quality of life and the risk of hospitalization are partially related to the activity level of patients with COPD. The effectiveness of pulmonary rehabilitation can be characterized by exercise physiologic variables and daily activity.

Methods: 12 patients with COPD (FEV1: 55±17%pred, age: 60±9 year, BMI: 21±4 kg/m2) performed 30-minute high intensity cycling 3 times per week for 8 weeks supervised by physiotherapists. Exercise physiologic variables and 12-hour daytime activity monitoring (Dynaport MiniMode, McRoberts BV) were measured before and after rehabilitation.

Results: None of the patients was hospitalized in this rehabilitation period. There was no change in maximal exercise capacity (WRmax: 75±17 vs. 82±21 Watt), but oxygen uptake (VO2:1,06±0,33 vs. 1,32±0,08 L/min.; p<0,05) and lactate threshold (LAT: 0,68±0,18 vs. 0,88±0,20 L/min.; p<0,05) improved significantly. Patients with COPD were more active after rehabilitation (lying: 26±16 vs. 12±11%; locomotion: 7±5 vs. 14±3%, p<0,05). Energy expenditure was reduced at rest after rehabilitation (lying: 22634±15352 vs. 12736±16514 Watt, p<0,05). Step counts improved significantly (3257±2267 vs. 5688±2920, p<0,05). The time of locomotion modestly correlated with post-rehab WRmax (r2=0,40, p<0,05) and FEV1 (%pred) (r2=0,25, p<0,05).

Conclusion: Activity monitoring contributes to the complex evaluation of rehabilitative interventions. Compared to maximal exercise capacity, change in activity level proved to be more sensitive to detect improvement in the status of COPD patients in this pilot study.
Older Age Is An Independent Risk Factor in AML
Authors: Thomas Buchner, Wolfgang E. Berdel, Claudia Haferlach, Susanne Schnittger, Torsten Haferlach, Hubert Serve, Carsten Müller-Tidow, Jan Braess, Karsten Spiekermann, Joachim Kienast, Rolf Mesters, Sarah Volpert, Peter Staib, Andreas Grüneisen, Wolfgang Kern, Albrecht Reichle, Wolf-Dieter Ludwig, Georg Maschmeyer, Ludwig Balleisen, Hartmut Eimermacher, Carlo Aul, Aristoteles Giagounidis, Herbert Rasche, Ruediger Hehlmann, Eva Lengfelder, Wolfgang Koepcke, Utz O. Krug, Maria Cristina Sauerland, Achim Heinecke, Bernhard Josef Woermann, Wolfgang Hiddemann
Journal: Blood (2008)
Pneumococcal Bacteremia Among Patients with Hematological Malignancies: Clinical Impact, Serotype Distribution and Antibiotic Resistance Profile in Tertiary-Care Centers
Authors: Sophie Savary Bélanger, Shi Hann Su, Sylvie Bélanger, Brigitte Lefebvre, Valéry Lavergne, Sandra Cohen, Annie-Claude Labbé
Journal: Blood (2012)